Fertin Pharma to be Acquired by Philip Morris International

Philip Morris International’s latest business move will help the tobacco manufacturer reach its goal of achieving a smoke-free portfolio. In a press release, Philip Morris International announced that it had entered into an agreement to acquire Fertin Pharma A/S, a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems. The value of…

Continue Reading On: TobaccoBusiness.com